Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Change in Receivables: 2018-2024

Historic Change in Receivables for Legend Biotech (LEGN) over the last 7 years, with Dec 2024 value amounting to $93.8 million.

  • Legend Biotech's Change in Receivables rose 108.67% to $25.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$72,000, marking a year-over-year decrease of 125.17%. This contributed to the annual value of $93.8 million for FY2024, which is 194.72% up from last year.
  • As of FY2024, Legend Biotech's Change in Receivables stood at $93.8 million, which was up 194.72% from -$99.0 million recorded in FY2023.
  • In the past 5 years, Legend Biotech's Change in Receivables registered a high of $93.8 million during FY2024, and its lowest value of -$99.0 million during FY2023.
  • In the last 3 years, Legend Biotech's Change in Receivables had a median value of $50.3 million in 2022 and averaged $15.0 million.
  • Per our database at Business Quant, Legend Biotech's Change in Receivables plummeted by 311.97% in 2020 and then skyrocketed by 194.72% in 2024.
  • Yearly analysis of 5 years shows Legend Biotech's Change in Receivables stood at -$45.0 million in 2020, then soared by 154.64% to $24.6 million in 2021, then skyrocketed by 104.64% to $50.3 million in 2022, then plummeted by 296.70% to -$99.0 million in 2023, then spiked by 194.72% to $93.8 million in 2024.